KINGS DAUGHTERS HOSPITAL — History
CCN 150069 | 3-year financial timeline | COVID resilience: 18/100
🛡️ Public data only — no PHI permitted on this instance.
$123M
Latest Revenue (FY2022)
+1.7%
Revenue CAGR (3yr)
-13.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $119M | $144M | $123M | -14.0% | +1.7% |
| Operating Expenses | $122M | $136M | $140M | +3.0% | +7.2% |
| Operating Margin | -2.5% | 5.0% | -13.8% | -375.2% | +0.0% |
| Net Income | $-3M | $7M | $-17M | -336.6% | +0.0% |
| Licensed Beds | 61 | 61 | 43 | -29.5% | -16.0% |
| Total Patient Days | 10,605 | 11,500 | 9,185 | -20.1% | -6.9% |
| Medicare Day % | 43% | 35% | 37% | +5.2% | -7.8% |
| Medicaid Day % | 15% | 21% | 22% | +2.9% | +20.9% |
COVID Impact & Recovery
Resilience Score: 18/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +3.5% ($119M → $123M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+1.7%
This Hospital
+7.6%
State Avg
Latest Margin
-13.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $125M | -19.4% |
| FY2024 (proj) | $127M | -25.1% |
| FY2025 (proj) | $130M | -30.7% |